Emerald Mutual Fund Advisers Trust’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.3M Hold
1,997,035
3.17% 1
2026
Q1
$69.9M Hold
1,997,035
3.39% 1
2025
Q4
$73.1M Hold
1,997,035
3.56% 1
2025
Q3
$59.4M Hold
1,997,035
3.07% 1
2025
Q2
$49.2M Buy
+1,997,035
New +$45.7M 2.99% 1
2025
Q1
Sell
-1,997,035
Closed -$48.7M 1
2024
Q4
$46.7M Buy
+1,997,035
New +$50.5M 2.84% 3

Other funds holding LFSC

Emerald Mutual Fund Advisers Trust's LFSC Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust held its F/m Emerald Life Sciences Innovation ETF (LFSC) position steady in Q2 2026 at 1,997,035 shares worth $90.3M. The position accounts for 3.17% of the portfolio, ranked #1.

Emerald Mutual Fund Advisers Trust first reported a position in LFSC in Q4 2024 and has held it in 6 quarters since. 8 funds tracked by Wall St. Rank hold LFSC as of Q2 2026.

  • Emerald Mutual Fund Advisers Trust held 1,997,035 shares of F/m Emerald Life Sciences Innovation ETF worth $90.3M as of Q2 2026.
  • Emerald Mutual Fund Advisers Trust left its F/m Emerald Life Sciences Innovation ETF share count unchanged in Q2 2026.
  • F/m Emerald Life Sciences Innovation ETF made up 3.17% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #1 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in F/m Emerald Life Sciences Innovation ETF in Q4 2024 and has held it in 6 quarters since.
  • 8 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.